Skip to content Skip to footer site map

Recovery.gov - Track the Money

Recovery.gov is the U.S. government's official website that provides easy access to data
related to Recovery Act spending and allows for the reporting of potential fraud, waste, and abuse.

Agency Reporting


< Back to Agency Plan
Program Plan
Department of Health and Human Services - Recovery Act - Comparative Effectiveness Research - AHRQ Recovery Plan
Updated 05/15/2009
Objectives
Program Purpose

The overarching goal of this program is to improve health outcomes by producing evidence to enhance medical decisions made by patients and their medical providers.


Public Benefits

This goal is achieved by conducting and supporting comparative effectiveness research. The Department of Health and Human Services uses the definition of comparative effectiveness research as set forth by the Federal Coordinating Council for CER:

Comparative effectiveness research is the conduct and synthesis of systematic research comparing different interventions and strategies to prevent, diagnose, treat and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. To provide this information, comparative effectiveness research must assess a comprehensive array of health-related outcomes for diverse patient populations. Defined interventions compared may include medications, procedures, medical and assistive devices and technologies, behavioral change strategies, and delivery system interventions. This research necessitates the development, expansion, and use of a variety of data sources and methods to assess comparative effectiveness.

Systematic research methods can include randomized controlled trials, meta-analyses, observational cohort analyses, and other new and emerging methodologies. Comparative effectiveness studies may compare similar treatments, such as competing drugs, or analyze very different approaches, such as surgery and drug therapy. Evaluation of treatments includes any potential medical intervention under consideration, whether prognostic, preventive, diagnostic, therapeutic, or palliative. Comparative effectiveness research may also address public health or systems interventions that affect health outcomes. Comparative effectiveness research is designed to inform patient and clinician decisions relevant to the unique circumstances of individual patients.

AHRQ will spend appropriated funds to research and provide information on the relative strengths and weaknesses of various medical interventions. Such research will give clinicians and patients valid information with which to make decisions that will improve the performance of the U.S. health care system. AHRQ’s comparative effectiveness research will support HHS strategic plan goal 1: improve the safety, quality, affordability and accessibility of health care, including behavioral health care and long-term care.


Measures
The measures have been revised to enrich the performance metrics for Recovery targets. In some instances, targets will not be available until additional baseline data has been collected.

MeasureTarget/Actual
2009201020112012
[-] HHS is working to develop cross-cutting outcome measures for comparative effectiveness research activities across the Department. Initial outcome measures will be developed by December 1, 2009.
----

Measure Information
Frequency : Long-term
Direction : No Data Available
Type : Outcome
Explanation : No Data Available
Unit : No Data Available
[-] Increase number of systematic reviews and summary guides available to patients, providers and policymakers to make health care decisions
----

Measure Information
Frequency : Quarterly
Direction : No Data Available
Type : Output
Explanation : The existing measures currently used to report AHRQ's comparative effectiveness programs' performance will be used. We will report outcome and outputs, to the extent possible, supported with funding appropriated under the Recovery Act as an incremental change from those supported by regular appropriations.

All AHRQ systematic reviews and summary guides are posted on the AHRQ Effective Health Care Program Web site, http://effectivehealthcare.ahrq.gov/.
Unit : No Data Available
[-] Increase number of organizations disseminating systematic reviews and summary guides to their constituents
----

Measure Information
Frequency : Annual
Direction : No Data Available
Type : Output
Explanation : The existing measures currently used to report AHRQ's comparative effectiveness programs' performance will be used. Performance measure Targets and Results will be adjusted to reflect ARRA funds once AHRQ's spend plan for comparative effectiveness funding for ARRA has been approved and announced to the public. We will report outcome and outputs, to the extent possible, supported with funding appropriated under ARRA as an incremental change from those supported by regular appropriations.

Requests for copies of AHRQ publications (ordered by title and publication number), are made to the AHRQ Publications Clearinghouse. Data will be provided bi-annually from the Publications Clearinghouse on the number of organizations requesting more than 50 copies of AHRQ comparative effectiveness research reports and summary guides.
Unit : No Data Available
[-] Increase amount of evidence from the CE Portfolio policymakers use as a foundation for population-base policies (Developmental/Interim Output)
----

Measure Information
Frequency : Annual
Direction : No Data Available
Type : Output
Explanation : The existing measures currently used to report AHRQ's comparative effectiveness programs' performance will be used. Performance measure Targets and Results will be adjusted to reflect ARRA funds once AHRQ's spend plan for comparative effectiveness funding for ARRA has been approved and announced to the public. We will report outcome and outputs, to the extent possible, supported with funding appropriated under ARRA as an incremental change from those supported by regular appropriations.

Data for this output is available from AHRQ's Medicaid Medical Director's Learning Network (MMDLN). At an annual meeting, members of MMDLN report on how they use AHRQ's comparative effectiveness research reports and summary guides.
Unit : No Data Available
[-] Number of competitive contracts and grants awarded to support AHRQ's Recovery Act comparative effectiveness research activities
----

Measure Information
Frequency : Quarterly
Direction : No Data Available
Type : Output
Explanation : Data for this output is available from AHRQ's accounting system - the Unified Financial Management System (UFMS).
Unit : No Data Available

Schedule and Milestones

AHRQ is currently developing a schedule with milestones and planned delivery dates for major phases of the program’s activities. As the Recovery Act requires, AHRQ will submit an operating plan for this program to the House and Senate Appropriation Committees prior to obligating Federal funds and not later than July 30, 2009. All funds available for AHRQ for comparative effectiveness research will be awarded in fiscal years 2009 and 2010.


Milestones
No Data Available

Projects and Activities

AHRQ is currently developing a plan that specifies the kind and scope of activities that AHRQ will fund to achieve the program’s objectives. AHRQ is considering various approaches for this program, such as expanding and broadening comparative effectiveness research activities initiated at AHRQ in response to Section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Section 1013 legislation was designed, in part, to increase the availability of research that would inform the real-world decisions facing patients and clinicians. Specifically, AHRQ’s investments using Recovery Act funds may expand its Effective Health Care (EHC) Program, which supports research activities performed using rigorous scientific methods within a previously-established process that emphasizes stakeholder involvement and transparency, that is designed to prioritize among pressing health issues, and whose products are designed for maximum usefulness for health care decision makers.


Review Process

All Recovery Act programs will be assessed by AHRQ staff on a quarterly basis for risk and to ensure that appropriate processes by which an organization's resources are directed, monitored, and measured are in place throughout the entire funding cycle. These assessments will be done consistent with the statutory requirements of the Federal Manager’s Financial Integrity Act and the Improper Payments Information Act, as well as OMB’s circular A-123 “Management’s Responsibility for Internal Control”.

AHRQ will build on current internal controls activities in accordance with both the Federal Managers' Financial Integrity Act (FMFIA) and Appendix A of OMB Circular A-123 to protect Recovery Act funds from misappropriation, mismanagement, waste, and abuse. During the A-123 review AHRQ will provide additional testing of key controls (if necessary) to ensure Recovery Act funds are included in AHRQ’s testing sample. Finally, AHRQ is in the process of drafting a comprehensive Risk Management Plan to identify, prioritize, and mitigate AHRQ and program specific-risks.

Historically, most of AHRQ’s grant awards are made to institutions that have had prior Federal funding and have demonstrated their ability to administer Federal funds. In accordance with HHS policy, for recipients that have not received prior Federal funding, non-profit status will be confirmed and a cursory assessment of the organization’s financial status will be made by AHRQ staff. These grants would be deemed high risk. Subsequent to funding, AHRQ will request that the OIG perform an audit to assess the recipients’ ability to properly expend and monitor grant funds where there are concerns. AHRQ anticipates that the majority of large grants will be awarded to institutions that have had prior Federal funding and have demonstrated their ability to administer Federal funds.

Contract awards are made to organizations that must demonstrate that they have an adequate accounting system that has been approved by a Federal agency. This accounting system must allow the organization to track Federal obligations, expenses, and reimbursements for each project funded. The adequacy of the accounting system is verified prior to award. AHRQ also provides a two level review of each invoice received to ensure that the expenses are allowable and appropriate to be distributed.

From a program standpoint, a potential risk for ineffective spending or waste is through non-performance of funded projects. To minimize this risk, AHRQ will carefully review and select projects for funding. The following criteria may be reviewed for each proposed project: understanding of the purpose and objectives of AHRQ’s comparative effectiveness research programs, technical approach, management plan, organizational experience, key personnel, stakeholder engagement, and facilities and database characteristics. AHRQ will also continue to standardize training required for program officials at the Agency working on contracts and grants. This will ensure effective oversight and management of contracts and grants and will decrease the risk of non-performance. AHRQ program officials will implement processes for identifying high and low performance which may include program officials overseeing project management plans and awardees submitting monthly status reports and quarterly self-assessments.


Cost and Performance Plan

AHRQ will be open and transparent in all of its grants competitions that involve spending of Recovery Act funding consistent with statutory and OMB guidance.

AHRQ will ensure that recipient reporting required by Section 1512 of the Recovery Act and OMB guidance is made available to the public on Recovery.gov by October 10, 2009. AHRQ will inform recipients of their reporting obligation through standard terms and conditions, grant announcements, contract solicitations, and other program guidance. AHRQ will provide technical assistance to grantees and contractors and fully utilize Project officers to ensure compliance with reporting requirements.

AHRQ will include in all grants and contract funding announcements the standard terms and conditions for Recovery Act funds. These terms and conditions will convey to recipients the reporting requirements that are outlined in Section 2.9 of the OMB February 18 Guidance. In addition, AHRQ grants and contracts management will be available for technical assistance.


Energy Efficiency Spending Plans

AHRQ will ensure that it complies with energy efficiency and green building requirements, if applicable. Little, if any, Recovery Act funds are expected to be used to fund equipment purchases. No Recovery Act funds will be used to fund construction projects.


Program Plan Award Types
No Data Available